PharmAthene

PharmAthene

PharmAthene

The development of effective countermeasures to a range of potential biological and chemical weapons is PharmAthene’s primary objective.
Founded
2001
Raised
$19.3M
Follow us
Alexa global traffic share
Latest funding
$19,300,000
Secondary market - 2009
Team Size
50+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when PharmAthene makes some noise.